CoChat

Human stem cell–derived monocytes and microglia‐like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2

Open access
Claes, Christel, Van Den Daele, Johanna, Boon, Ruben, Schouteden, Sarah, Colombo, Alessio, Monasor, Laura Sebastian, Fiers, Mark, Ordovás, Laura, Nami, FatemehArefeh, Bohrmann, Bernd, Tahirovic, Sabina, De Strooper, Bart, Verfaillie, Catherine M. · 2019 · Alzheimer's & Dementia
Cited by 80

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Introduction: Murine microglia expressing the Alzheimer's disease–linked TREM2R47H mutation display variable decrease in phagocytosis, while impaired phagocytosis is reported following loss of TREM2. However, no data exist on TREM2+/R47H human microglia. Therefore, we created human pluripotent stem cell (hPSC) monocytes and transdifferentiated microglia‐like cells (tMGs) to examine the effect of the TREM2+/R47H mutation and loss of TREM2 on phagocytosis. Methods: We generated isogenic TREM2+/R47H, TREM2+/−, and TREM2−/− hPSCs using CRISPR/Cas9. Following differentiation to monocytes and tMGs, we studied the uptake of Escherichia coli fragments and analyzed amyloid plaque clearance from cryosections of APP/PS1+/− mouse brains. Results: We demonstrated that tMGs resemble cultured human microglia. TREM2+/− and TREM2−/− hPSC monocytes and tMGs phagocytosed significantly less E. coli fragments and cleared less amyloid plaques than wild‐type hPSC progeny, with no difference for TREM2+/R47H progeny. Discussion: In vitro phagocytosis of hPSC monocytes and tMGs was not affected by the TREM2+/R47H mutation but was significantly impaired in TREM2+/− and TREM2−/− progeny.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2018.09.006

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 80

Metadata

Authors
Claes, C., Van Den Daele, J., Boon, R., Schouteden, S., Colombo, A., Monasor, L. S., Fiers, M., Ordovás, L., Nami, F., Bohrmann, B., Tahirovic, S., De Strooper, B., & Verfaillie, C. M.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2018-11-12
Volume
15
Issue
3
Pages
453-464
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2900663815
Cited by
80
References
31
FWCI
3.95
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human stem cell–derived monocytes and microglia‐like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2. https://app.cochat.ai/papers/10.1016/j.jalz.2018.09.006
The paper
Claes, C., Van Den Daele, J., Boon, R., Schouteden, S., Colombo, A., Monasor, L. S., Fiers, M., Ordovás, L., Nami, F., Bohrmann, B., Tahirovic, S., De Strooper, B., & Verfaillie, C. M. (2019). Human stem cell–derived monocytes and microglia‐like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2018.09.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.